masitinib, masitinib, Placebo to 100mg masitinib, Placebo to 200mg masitinib
AB20006
Phase 2 small_molecule active
Quick answer
masitinib, masitinib, Placebo to 100mg masitinib, Placebo to 200mg masitinib for Mast cell activation syndrome is a Phase 2 program (small_molecule) at AB Science with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AB Science
- Indication
- Mast cell activation syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active